AstraZeneca (AZN) to Acquire Spirogen in Up to $440M Deal

October 15, 2013 6:43 AM EDT Send to a Friend
Auven Therapeutics, the global private equity company focused on accelerated development of breakthrough therapeutic drugs addressing unmet medical needs, today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login